Larvol Delta - AusperBio-Completes-120-Million-Series-C-Financing-to-Advance-AHB137-Toward-Potential-Commercialization-and-Expand-NextGeneration-HBV-Therapies

AHB-137 - AusperBio

https://www.prnewswire.com/news-releases/ausperbio-completes-120-million-series-c-financing-to-advance-ahb-137-toward-potential-commercialization-and-expand-next-generation-hbv-therapies-302862321.html

Aug 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next